Digoxin
(Lanoxin, Lanoxicaps)
|
Category:
Description:
Indications:
-
CHF
in patients receiving diuretics and ACE inhibitors
-
Control
ventricular response rate in atrial fibrillation
-
Atrial
flutter
-
Paroxysmal
atrial tachycardia (PAT)
-
Cardiogenic
shock
Contraindications:
-
Ventricular
tachycardia
-
Ventricular
fibrillation
Precautions:
-
Pregnancy
category C; passes readily into the fetus; incompatible with breast
feeding
-
Hypokalemia,
hypomagnesemia, hypothyroidism, hypercalcemia
-
Sick
sinus syndrom, acute MI, AV block, Wolff-Parkinson-White syndrom
-
severe
pulmonary disease
Adverse
Reactions (Side Effects):
-
CNS:
anorexia, apathy, confusion, delirium, disorientation, EEG
abnormalities, hallucinations, headache, mental depression, neuralgia,
seizures, weakness
-
CV:
atrial fibrillation, AV block, bradycardia, PVC’s, ventricular
fibrillation, ventricular tachycardia
-
EENT:
blurred vision, yellow or green vision, halo effect vision
-
GI:
abdominal discomfort, diarrhea, hemorrhagic necrosis of the
intestines, nausea, vomiting
-
HEME:
eosinophilia, thrombocytopenia
|
Dosage:
Administered
orally (tablets, gelcaps, elixir) or intravenously (slowly over 5 minutes)
-
Adult:
-
Child
>10 years:
-
Child
5-10 years:
-
Child
2-5 years:
-
Child
1-24 months:
-
Full
term infant:
-
Premature
infant:
|
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
|